Anavex Life Sciences Corp (AVXL)

[hnbadger1]

WOW-84.7% reduction in decline at 48 weeks of blarcamesine treatment vs placebo on the primary cognitive endpoint ADAS-Cog13



Anavex Life Sciences Announces Oral
Blarcamesine Cognitive Resilience Results
Approximating Normal Aging in New Precision Medicine Clinical Data from Phase IIb/III Alzheimer's Disease Trial

https://www.anavex.com/post/anavex-life-sciences-announces-oral-blarcamesine-cognitive-resilience-results-approximating-normal-a